{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T16:30:47Z","timestamp":1745857847456},"reference-count":50,"publisher":"Portland Press Ltd.","issue":"4","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,8,1]]},"abstract":"<jats:p>Considering the many differences between mice and humans, it is perhaps surprising how well mice model late-onset human neurodegenerative disease. Models of Alzheimer's disease, frontotemporal dementia, Parkinson's disease and Huntington's disease show some striking similarities to the corresponding human pathologies in terms of axonal transport disruption, protein aggregation, synapse loss and some behavioural phenotypes. However, there are also major differences. To extrapolate from mouse models to human disease, we need to understand how these differences relate to intrinsic limitations of the mouse system and to the effects of transgene overexpression. In the present paper, we use examples from an amyloid-overexpression model and a mutant-tau-knockin model to illustrate what we learn from each type of approach and what the limitations are. Finally, we discuss the further contributions that knockin and similar approaches can make to understanding pathogenesis and how best to model disorders of aging in a short-lived mammal.<\/jats:p>","DOI":"10.1042\/bst0390933","type":"journal-article","created":{"date-parts":[[2011,7,26]],"date-time":"2011-07-26T12:05:03Z","timestamp":1311681903000},"page":"933-938","update-policy":"http:\/\/dx.doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Modelling early responses to neurodegenerative mutations in mice"],"prefix":"10.1042","volume":"39","author":[{"given":"Jonathan","family":"Gilley","sequence":"first","affiliation":[{"name":"Laboratory of Signalling and Cell Fate, Babraham Institute, Cambridge CB22 3AT, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Adalbert","sequence":"additional","affiliation":[{"name":"Laboratory of Signalling and Cell Fate, Babraham Institute, Cambridge CB22 3AT, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael\u00a0P.","family":"Coleman","sequence":"additional","affiliation":[{"name":"Laboratory of Signalling and Cell Fate, Babraham Institute, Cambridge CB22 3AT, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2011,7,20]]},"reference":[{"key":"2021111719413537700_B1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0165-3806(03)00056-7","article-title":"Isoforms changes of tau protein during development in various species","volume":"142","author":"Takuma","year":"2003","journal-title":"Dev. Brain Res."},{"key":"2021111719413537700_B2","doi-asserted-by":"crossref","first-page":"8473","DOI":"10.1523\/JNEUROSCI.21-21-08473.2001","article-title":"Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice","volume":"21","author":"Li","year":"2001","journal-title":"J. Neurosci."},{"key":"2021111719413537700_B3","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/brain\/awn312","article-title":"Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies","volume":"132","author":"Adalbert","year":"2009","journal-title":"Brain"},{"key":"2021111719413537700_B4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1523\/JNEUROSCI.4308-05.2006","article-title":"Parkinson's disease \u03b1-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death","volume":"26","author":"Martin","year":"2006","journal-title":"J. Neurosci."},{"key":"2021111719413537700_B5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0166-2236(00)01721-5","article-title":"Loss of normal huntingtin function: new developments in Huntington's disease research","volume":"24","author":"Cattaneo","year":"2001","journal-title":"Trends Neurosci."},{"key":"2021111719413537700_B6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bbadis.2004.06.018","article-title":"Tau alteration and neuronal degeneration in tauopathies: mechanisms and models","volume":"1739","author":"Brandt","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"2021111719413537700_B7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bbadis.2004.07.002","article-title":"Inability of tau to properly regulate neuronal microtubule dynamics: a loss-of-function mechanism by which tau might mediate neuronal cell death","volume":"1739","author":"Feinstein","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"2021111719413537700_B8","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/nn0905-1136","article-title":"Pathological tau: a loss of normal function or a gain in toxicity?","volume":"8","author":"Trojanowski","year":"2005","journal-title":"Nat. Neurosci."},{"key":"2021111719413537700_B9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"257","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"2021111719413537700_B10","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1073\/pnas.88.4.1461","article-title":"Amyloid precursor protein in aged nonhuman primates","volume":"88","author":"Martin","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111719413537700_B11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/nlme.1996.0039","article-title":"\u03b2-Amyloid accumulation correlates with cognitive dysfunction in the aged canine","volume":"66","author":"Cummings","year":"1996","journal-title":"Neurobiol. Learn. Mem."},{"key":"2021111719413537700_B12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/cne.10536","article-title":"PDAPP; YFP double transgenic mice: a tool to study amyloid-\u03b2 associated changes in axonal, dendritic, and synaptic structures","volume":"456","author":"Brendza","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"2021111719413537700_B13","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.1523\/JNEUROSCI.1879-05.2005","article-title":"Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy","volume":"25","author":"Spires","year":"2005","journal-title":"J. Neurosci."},{"key":"2021111719413537700_B14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000211873","article-title":"Miliare Nekrosen mit drusigen Wucherungen der Neurofibrillen, eine regelma\u00dfe Ver\u00e4nderung der Hirnrinde bei seniler Demenz","volume":"2","author":"Fischer","year":"1907","journal-title":"Monatsschr. Psychiatr. Neurol."},{"key":"2021111719413537700_B15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1196\/annals.1379.003","article-title":"Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer's disease","volume":"1097","author":"Grutzendler","year":"2007","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"2021111719413537700_B16","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/nn1335","article-title":"Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches","volume":"7","author":"Tsai","year":"2004","journal-title":"Nat. Neurosci."},{"key":"2021111719413537700_B17","doi-asserted-by":"crossref","first-page":"8552","DOI":"10.1523\/JNEUROSCI.19-19-08552.1999","article-title":"Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice","volume":"19","author":"Phinney","year":"1999","journal-title":"J. Neurosci."},{"key":"2021111719413537700_B18","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer's disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"2021111719413537700_B19","doi-asserted-by":"crossref","first-page":"21562","DOI":"10.1074\/jbc.M100710200","article-title":"Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695","volume":"276","author":"Chishti","year":"2001","journal-title":"J. Biol. Chem."},{"key":"2021111719413537700_B20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0896-6273(00)00084-2","article-title":"Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP","volume":"28","author":"Feng","year":"2000","journal-title":"Neuron"},{"key":"2021111719413537700_B21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.neurobiolaging.2007.06.002","article-title":"Late onset distal axonal swelling in YFP-H transgenic mice","volume":"30","author":"Bridge","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"2021111719413537700_B22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2007.05.010","article-title":"Knock-out and transgenic mouse models of tauopathies","volume":"30","author":"Denk","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"2021111719413537700_B23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/187152710791556131","article-title":"Transgenic mouse models of tauopathy in drug discovery","volume":"9","author":"Noble","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"2021111719413537700_B24","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/j.1460-2075.1995.tb07116.x","article-title":"Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform","volume":"14","author":"Gotz","year":"1995","journal-title":"EMBO J."},{"key":"2021111719413537700_B25","article-title":"Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a \u201cP301L\u201d tau knockin mouse","author":"Gilley","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"2021111719413537700_B26","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1074\/jbc.M006531200","article-title":"Tau filament formation in transgenic mice expressing P301L tau","volume":"276","author":"Gotz","year":"2001","journal-title":"J. Biol. Chem."},{"key":"2021111719413537700_B27","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/78078","article-title":"Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein","volume":"25","author":"Lewis","year":"2000","journal-title":"Nat. Genet."},{"key":"2021111719413537700_B28","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.2353\/ajpath.2006.051250","article-title":"Cortical neuronal and glial pathology in TgTauP301L transgenic mice: neuronal degeneration, memory disturbance, and phenotypic variation","volume":"169","author":"Murakami","year":"2006","journal-title":"Am. J. Pathol."},{"key":"2021111719413537700_B29","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.1113694","article-title":"Tau suppression in a neurodegenerative mouse model improves memory function","volume":"309","author":"Santacruz","year":"2005","journal-title":"Science"},{"key":"2021111719413537700_B30","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1074\/jbc.M409876200","article-title":"Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R\/2N transgenic mice","volume":"280","author":"Terwel","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2021111719413537700_B31","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.2353\/ajpath.2009.090462","article-title":"Overexpression of wild-type murine tau results in progressive tauopathy and neurodegeneration","volume":"175","author":"Adams","year":"2009","journal-title":"Am. J. Pathol."},{"key":"2021111719413537700_B32","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1471-4159.2003.01879.x","article-title":"Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms","volume":"86","author":"Andorfer","year":"2003","journal-title":"J. Neurochem."},{"key":"2021111719413537700_B33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0002-9440(10)65272-8","article-title":"Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease","volume":"154","author":"Brion","year":"1999","journal-title":"Am. J. Pathol."},{"key":"2021111719413537700_B34","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0896-6273(00)81127-7","article-title":"Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform","volume":"24","author":"Ishihara","year":"1999","journal-title":"Neuron"},{"key":"2021111719413537700_B35","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s004010051148","article-title":"Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein","volume":"99","author":"Probst","year":"2000","journal-title":"Acta Neuropathol."},{"key":"2021111719413537700_B36","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0002-9440(10)63997-1","article-title":"Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice","volume":"158","author":"Ishihara","year":"2001","journal-title":"Am. J. Pathol."},{"key":"2021111719413537700_B37","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0896-6273(03)00627-5","article-title":"Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles","volume":"40","author":"Cruz","year":"2003","journal-title":"Neuron"},{"key":"2021111719413537700_B38","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nature01832","article-title":"Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration","volume":"424","author":"Liou","year":"2003","journal-title":"Nature"},{"key":"2021111719413537700_B39","first-page":"11","article-title":"A new mouse model of ALS carrying a point mutation in the mouse Sod1 gene","volume-title":"21st International Symposium on ALS\/MND","author":"Joyce","year":"2010"},{"key":"2021111719413537700_B40","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","article-title":"Neurological abnormalities in a knock-in mouse model of Huntington's disease","volume":"10","author":"Lin","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"2021111719413537700_B41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cne.10776","article-title":"Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats","volume":"465","author":"Menalled","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"2021111719413537700_B42","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1093\/hmg\/ddq137","article-title":"TDP-43 and FUS\/TLS: emerging roles in RNA processing and neurodegeneration","volume":"19","author":"Lagier-Tourenne","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"2021111719413537700_B43","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular A\u03b2 and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"2021111719413537700_B44","doi-asserted-by":"crossref","first-page":"874\u2013880","DOI":"10.1042\/BST0390874","article-title":"FDG\u2013PET imaging, EEG and sleep phenotypes as translational biomarkers for research in Alzheimer's disease","volume":"39","author":"Platt","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"2021111719413537700_B45","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1016\/j.ajpath.2011.02.012","article-title":"Inflammation induced by infection potentiates tau pathological features in transgenic mice","volume":"178","author":"Sy","year":"2011","journal-title":"Am. J. Pathol."},{"key":"2021111719413537700_B46","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"\u03b1-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"2021111719413537700_B47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuron.2006.05.022","article-title":"Increased APP expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration","volume":"51","author":"Salehi","year":"2006","journal-title":"Neuron"},{"key":"2021111719413537700_B48","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1523\/JNEUROSCI.20-16-06021.2000","article-title":"Neuropathology in mice expressing human \u03b1-synuclein","volume":"20","author":"van\u00a0der\u00a0Putten","year":"2000","journal-title":"J. Neurosci."},{"key":"2021111719413537700_B49","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jnr.10231","article-title":"Differential neuropathological alterations in transgenic mice expressing \u03b1-synuclein from the platelet-derived growth factor and Thy-1 promoters","volume":"68","author":"Rockenstein","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"2021111719413537700_B50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","article-title":"Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease","volume":"101","author":"Yamamoto","year":"2000","journal-title":"Cell"}],"container-title":["Biochemical Society Transactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/39\/4\/933\/548365\/bst0390933.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/39\/4\/933\/548365\/bst0390933.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T22:06:35Z","timestamp":1637186795000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article\/39\/4\/933\/65175\/Modelling-early-responses-to-neurodegenerative"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,20]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,7,20]]},"published-print":{"date-parts":[[2011,8,1]]}},"URL":"https:\/\/doi.org\/10.1042\/bst0390933","relation":{},"ISSN":["0300-5127","1470-8752"],"issn-type":[{"value":"0300-5127","type":"print"},{"value":"1470-8752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,20]]}}}